Target intelligence / Profile preview

Ubiquitin conjugating enzyme E2 V2 pseudogene 3 (UBE2V2P3)

Target: UBE2V2P3
Molecular classification: Other (pseudogene)

Overview

Ubiquitin conjugating enzyme E2 V2 pseudogene 3 (UBE2V2P3) is a processed pseudogene found in the human genome. While its name indicates similarity to the ubiquitin-conjugating enzyme E2 V2 (UBE2V2), it does not produce a functional protein and has no assigned physiological, pharmacological, or pathological function. It is not recognized as a receptor, enzyme, transporter, or any other druggable or disease-relevant target.

Other names: UBE2V2P3NCBI Gene ID 100421341

Mechanism of action

Not applicable

Beyond the preview

Go deeper on Ubiquitin conjugating enzyme E2 V2 pseudogene 3 (UBE2V2P3).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

Drug candidates
Developers
Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

Trial design
Status
Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

Programs
Modalities
Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

Publications
Sources
Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

Patents
Assignees
Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

Biology
Development news
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Ubiquitin conjugating enzyme E2 V2 pseudogene 3 (UBE2V2P3).

Explore the full profile